• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration

    2021-12-17 03:15:56XinFnHowiZhnYnZhnxinChnXioonSun

    Xin Fn Ho wi Zhn Yn Zhn xin Chn Xioon Sun

    a Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    b Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    c Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    d National Clinical Research Center for Eye Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    e Ningbo Hygeia Medical Technology Co., Ltd., Ningbo 315201, China

    f School of Bioengineering, Dalian University of Technology, Dalian 116024, China

    g College of Pharmacy, Dalian Medical University, Dalian 116044, China

    Keywords: Age-related macular degeneration Anti-angiogenesis Gene therapy Polymer Vascular endothelial growth factor

    ABSTRACT In light of the intriguing potential of anti-angiogenic approach in suppressing choroidal neovascularization,we attempted to elaborate synthetic gene delivery systems encapsulating anti-angiogenic plasmid DNA as alternatives of clinical antibody-based therapeutics.Herein,block copolymer of cyclic Arg-Gly-Asp-poly(ethylene glycol)-poly(lysine-thiol) [RGD-PEG-PLys(thiol)]with multifunctional components was tailored in manufacture of core-shell DNA delivery nanoparticulates.Note that the polycationic PLys segments were electrostatically complexed with anionic plasmid DNA into nanoscaled core,and the tethered biocompatible PEG segments presented as the spatial shell (minimizing non-specific reactions in biological milieu).Furthermore,the aforementioned self-assembly was introduced with redox-responsive disulfide crosslinking due to the thiol coupling.Hence,reversible stabilities,namely stable in extracellular milieu but susceptible to disassemble for liberation of the DNA payloads in intracellular reducing microenvironment,were verified to facilitate transcellular gene transportation.In addition,RGD was installed onto the surface of the proposed self-assemblies with aim of targeted accumulation and internalization into angiogenic endothelial cells given that RGD receptors were specifically overexpressed on their cytomembrane surface.The proposed anti-angiogenic DNA therapeutics were validated to exert efficient expression of anti-angiogenic proteins in endothelial cells and elicit potent inhibition of ocular neovasculature post intravitreous administration.Hence,the present study approved the potential of gene therapy in treatment of choroidal neovascularization.In light of sustainable gene expression properties of DNA therapeutics,our proposed synthetic gene delivery system inspired prosperous potentials in long-term treatment of choroidal neovascularization,which should be emphasized to develop further towards clinical translations.

    1.Introduction

    Indulgence in electronic displays,owing to their high-energy visible light and ultraviolet,has prompted a rapidly growing population of choroidal neovascularization (CNV),which has been acknowledged to be a major cause of blindness across the world.In reference to the recent statistics,CNV comprises an estimated 2.5% of people aged over 40 years [1–3].Note that wet age-related macular degeneration (wAMD) was characterized by CNV,which provokes progressive leakage of blood and fluid,eventually leading to vision loss [4–6].In principle,CNV is stimulated by vascular endothelial growth factor (VEGF),diffusible cytokines that prompt angiogenesis and vascular permeability [7,8].Pertaining to the clinical therapeutic regime,intravitreal administration of VEGF antagonists (e.g.ranibizumab or bevacizumab) that specifically bind to the VEGF,have been verified to be a valid approach in suppressing CNV progression of wAMD and improving visual acuity [9–14].Nonetheless,the aforementioned antibody-based therapeutics are required to be repeatedly administered at 4–8 weeks interval,which not only conflicts the patient compliance but also increases the risks of ocular inflammation,retinal injury and endophthalmitis [15,16].To this drawback,gene therapy as alternative to antibody-based therapeutics is desirable in light of long-term protein expression of the encoded therapeutic gene in the affected cells [17,18].For instance,genomic therapeutics recently developed by our laboratory have demonstrated intriguingly consistent gene expression in cell spheroids over 90 days,and the levels of the expressed proteins were recorded to be appreciably constant [19].Hence,this tempting constant gene expression profile is postulated to not only allow reduced dosage frequencies (thus improved patient compliance) but also contribute to improved therapeutic outcomes in respect to the constant retention of high level of therapeutic proteins in the pathologic sites.

    However,to accomplish gene therapy,appropriate delivery systems are imperative to transport the inherently biologically fragile DNA to the cell interior (cell nucleus) for efficient gene expression since the supramolecular DNA owing to its large scale (micrometer) and intrinsic negative-charge forbids its diffusion across the lipophilic and negatively charged cytomembranes,not to mention the other biological barriers hindering the successful intracellular gene transportation [20,21].It should be noted for viral vectors,despite their tempting transfection efficiencies,whose fatal concerns (e.g.severe immunogenicity,limited gene-loading capacity and difficulties in industrial scale-up) motivate us to seek an alternative approach in manufacture of delivery vehicles for intracellular gene transportation [22,23].To the essential prerequisites for gene delivery,we intended to exploit materials-based molecular design in manufacture of non-viral synthetic gene delivery systems to accomplish gene therapy.

    In the present research,the negatively charged plasmid DNA was schemed to electrostatically complex with cationic block copolymers of poly(ethylene glycol)-polylysine (PEG-PLys).Consequently,the DNA condensates initialized by electrostatic complexation with the cationic PLys segments as the internal core,was postulated to be surrounded by the hydrophilic and biocompatible PEG shell.With the aim of adequate colloidal stability in the physiological environment,thiol groups were introduced into the side chains of PLys with the intention of crosslinking of the internal pDNA/PLys core by means of disulfide linkage between the thiols.Notably,the disulfide linkage was fairly stable in the extracellular milieu (relative oxidizing environments),thereby affording substantial stability to withstand the potential structural dissociation in the bloodstream or extracellular milieu.On the contrary,the disulfide bond is susceptible to cleavage in the intracellular compartments.Note that the intracellular milieu is characterized to be remarkably reducing compartments,intracellular structural disassembly from the proposed self-assemblies could be readily anticipated in subsequence to disulfide cleavage,which consequently facilitates the pDNA release from the aforementioned DNA self-assemblies for smooth gene expression machinery.On the other hand,targeting moieties of cyclic Arg-Gly-Asp (RGD) peptide were also installed onto the surface of the PEGylated self-assemblies.In view the specific affinities of RGD peptide to the angiogenic vasculatures (the receptors of RGD,including

    α

    β

    and

    α

    β

    integrins,are overexpressed on the angiogenic endothelial cells),hence preferential accumulation and thus efficient protein expression of therapeutic proteins (anti-VEGF) in CNV could be envisioned in the treatment of wAMD.

    2.Materials and methods

    2.1.Materials

    α

    -Methoxy-

    ω

    -amino-PEG (M w 12,000) and acetal-PEG-NH(M w 12,000) was purchased from SinoPEG Co.(Xiamen,China).N-Trifluoroacetyl-L-lysine N-carboxyanhydride [Lys(TFA)-NCA]was purchased from Hubei Jusheng Co.(Wuhan,China).Dithiothreitol (DTT),diethylenetriamine (DET),N,N-dimethylformamide (DMF),dichloromethane,benzene,and trifluoroacetic acid were purchased from Wako Pure Chemical Industries,Ltd.N-succinimidyl-3-(2-pyridyldithiol)propionate (SPDP) was purchased from Santa Cruz Biotechnology,Inc.(Santa Cruz,CA).Fetal bovine serum (FBS) was purchased from Dainippon Sumitomo Parma Co.,Ltd.(Osaka,Japan).Cell culture lysis buffer and luciferase Assay System Kit was purchased from Promega Co.(Madison,WI).Dulbecco’s modified Eagle’s medium (DMEM) was purchased from Sigma–Aldrich (St.Louis,MO).In pertinent to the cellular uptake and intracellular distribution assay,pDNA was labeled with Cy5 using a Label IT Nucleic Acid Labeling Kit from Mirus Bio Corporation (Madison,WI) according to the manufacturer’s protocol.For aqueous phase SEC,LC-2000 system (JASCO,Tokyo,Japan) equipped with Superdex200 10/300 GL (GE Healthcare,Tokyo,Japan) and a UV detector was used for characterizations.All animal experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals as stated by the guidelines of Shanghai General Hospital (Shanghai Jiao Tong University School of Medicine).

    2.2.Polymer synthesis

    Block copolymer of PEG-PLys(thiol) and RGD-PEG-PLys(thiol) was synthesized based on ring opening polymerization.In brief,amine-functionalized Meo-PEG-NH 2 was employed as macroinitiator for polymerization of monomers of Lys(TFA)-NCA for block copolymeric PEG-PLys(TFA).The protective TFA groups was removed by hydrolysis reaction in NaOH.Furthermore,thiol groups were introduced into the side chain of the synthetic PLys segment in block copolymeric PEG-PLys based on its reaction with SPDP.The yielded PEG-PLys(SPDP) was transferred under treatment of DTT to obtain PEG-PLys(thiol).On the other hand,acetal-PEG-NHwas employed for synthesis of acetal-PEG-PLys(thiol) by following the similar synthetic route,which was transferred for acidic treatment to yield aldehyde-PEG-PLys(thiol).Cysteine-functionalized cyclic RGD was attempted for reaction with aldehyde group of aldehyde-PEG-PLys(thiol) to obtain the ultimate RGD-PEG-PLys(thiol).The detailed synthetic procedures were described in Supporting Information.

    2.3.Dynamic light scattering (DLS)

    The hydrodynamic diameters of the formulated pDNA delivery systems were measured by DLS (Zetasizer nanoseries,Malvern Instruments Ltd.,Worchestershire,UK).All DLS measurements were conducted independently for at least three times at 25 °C.Note that the rate of decay in the photon correlation function was analyzed by referring to a cumulant method.Accordingly,the yielded hydrodynamic diameters were concluded based on the Stokes-Einstein equation.

    2.4.Cellular uptake

    Human umbilical vein endothelial cells (HUVECs) were seeded onto 6-well culture plates (50 000 cells/well) in cell culture medium (2 ml) containing 10% FBS and 1% antibiotics (penicillin and streptomycin) and incubated in a humidified atmosphere supplemented with 5% CO 2 at 37 °C.After 24 h incubation,the medium was replaced with fresh medium.The cells were treated by addition of PEG-PLys/pDNA,PEG-PLys(thiol)/pDNA and RDG-PEG-PLys(thiol)/pDNA (1 μg of Cy5-labeled pDNA/well) and followed by another 24 h incubation.The medium was discarded,and the cells were washed three times with ice-cold PBS to remove extracellular fluorescence.Furthermore,the cells were subjected to trypsin-EDTA treatment,and the trypsinized cells were harvested and resuspended in 1 ml ice-cold PBS.the cell suspension was filtered through a nylon mesh and transferred for analysis by a BDLSR II flow cytometer equipped with FACS-Divasoftware (BD Biosciences,Franklin Lakes,NJ) to quantify the intracellular pDNA quantity.Note that the cellular uptake efficiencies were expressed as the mean fluorescence intensities from Cy5-pDNA based on three independent samples (

    n

    =3).

    2.5.Gene expression efficiency

    HUVECs were seeded onto 24-well culture plates (20 000 cells/well) in 400 μl cell culture medium containing 10% FBS and 1% antibiotics (penicillin and streptomycin) and incubated in a humidified atmosphere supplemented with 5% CO 2 at 37 °C.At 24 h post incubation,gene delivery systems containing the reporter pDNA od CAG-Luc were added to each well for 48 h incubation.Note that fresh medium was replaced at 24 h interval.At 48 h post transfection,the cells were washed three times with 400 μl ice-cold PBS and lysed in 150 μl cell lysis buffer at 37 °C for 10 min.Furthermore,20 μl of the cell lysate was transferred into a 96-well luminometry plate,followed by addition of 100 μl of Luciferase Assay Reagent (Promega,Madison,WI),and allowed for 15 min reaction.The expressed Luc protein was quantified for 10 s recording of the photoluminescence intensities by Mithras LB 940 (Berthold Technologies,Bad Wildbad,Germany).Meanwhile,the quantities of the total protein in the cell lysate was quantified according to the classical Micro BCAProtein Assay Kit (Pierce,Rockford,IL).The obtained Luc activities was normalized against the corresponding quantities of the total protein in the cell lysates.Herein,the gene expression levels were expressed as relative light units (RLU) per mg of protein (RLU/mg protein) (

    n

    =4).

    2.6.Animals

    C57BL/6 mice (approximate 7 weeks,20 g) were used in anti-CNV study.Note that all the animal experiments were conducted strictly according to the guidelines of the ARVO statement for the Use of Animals in Ophthalmic and Vision Research.The experimental protocols were approved by Institutional Animal Care and Use Committee of Shanghai Jiao Tong University (Shanghai,China).The mice were housed and subjected to containment in the animal care services facility with 12 h light/dark cycle and constant access to nourishments.

    2.7.Laser-induced CNV

    CNV was established according to our previously reported protocol.In brief,pupil dilatation was performed with tropicamide (Santen,Osaka,Japan),followed by anesthetization based on intraperitoneal injection of 1% pentobarbital sodium (0.1 ml/10 g body weight,Guge Biotech,Wuhan,China) into C57BL/6 mice.To proceed photoagulation,loxacin eye ointment (Xing Qi Pharmaceutical Companies,Shenyang,China) was placed on top of corneal,and four laser spots were located at the vicinities of the optic nerve head with an argon laser (110 mW,100 ms,50 μm,OcuLight Infrared Laser System 810 nm,Iridex Corp.,Mountain View,CA,USA).Appearance of a gray bubble indicative of the rupture of Bruch’s membrane were included.If retinal bleeding occurred,the animal was eliminated.Eyes were enucleated at different time points.

    2.8.Intravitreal injection

    Synthetic gene delivery systems containing sFlt-1 were intravitreal administered into the vitreous cavity using fine,32-G needles and 10 μl syringes (cat.No 80,330;both form Hamilton,Reno,NV).Note that the injection process was carefully conducted with the aids of microscope through the flattened cornea (covered with ointment),and the tip of the needle is required to penetrate the sclera,choroid,and retina to reach the vitreous cavity.An approximate volume of 2 μl per injection was applied to each eye.

    2.9.Fluorescence angiography

    FA imaging was conducted on day 7 post photocoagulation to assess the severity of CNV leakage.Prior to FA imaging,mice were subjected to sequential intraperitoneal dosage of 1% sodium pentobarbital (Guge Biotech,Wuhan,China) for anesthetization at 5 μl/g body weight and 10% fluorescein sodium (0.5 ml,Fluorescite,Alcon,Tokyo,Japan) for bio-imaging.Fundus angiogram photos were captured at the middle stage (2–3 min post injection of fluorescein sodium) using a digital fundus camera (Heidelberg Retina Angiograph,Vista,CA).Furthermore,the relative fluorescence intensity of each CNV lesion was quantified with the aids of ImageJ platform (National Institutes of Health,Bethesda,MD).The average intensity of each CNV lesion with leakage was calculated according to our previously reported protocol (Burgess et al.,2010).In brief,an outline was drawn to encompass each CNV area,and mean fluorescence was measured,along with three adjacent background readings.The total corrected CNV fluorescence (TCCF)=integrated density– (area of selected area ×mean fluorescence of background readings),was calculated.This TCCF was equalized against the mean TCCF of retina vessels,with results presented as fold increase over interphase levels.We defined the intensity of retinal vessels as one and the avascular area as zero and the signal intensity for each pixel was represented from zero (darkest) to one (brightest).

    2.10.Perfusion fixation

    Immunofluorescence procedures require perfusion fixation to stabilize the proteins or peptides in the choroid in order to allow for subsequent antibody binding to the antigenic site on those proteins or peptides.At end points of Day 7 after laser and sFlt-1 treatment,mice were perfused transcardially with cold 4% paraformaldehyde using a previously described protocol with minor modifications (Gerfen,2003).In brief,mice were administered with an over dose (0.2 ml) of 1% sodium pentobarbital and monitored until the point when the animal fails to respond to pinching of the foot.Incisions in the abdomen and diaphragm were made to expose the heart and perfusion needle was placed into ascending aorta.Cold 4% paraformaldehyde was poured into left ventricle of mouse through a peristaltic perfusion pump (Cole-Parmer Masterflex,NY).Twitching of muscles suggests that the perfusion is proceeding properly.After the effluent runs clear,pump was stopped,eyes and spleens were harvested,post-fixed for 2 h and then placed in PBS to make choroidal flatmounts or put into 30% sucrose solutions to make frozen sections.

    2.11.Choroidal flatmount and immunofluorescence staining

    Choroidal flatmounts were performed under an operating microscope (Olympus,Tokyo,Japan) subsequent to perfusion fixation and post-fixation.In brief,the cornea,lens and vitreous were removed from the harvested eye.The retina was carefully dissected from the choroid.Furthermore,six radial incisions were applied to the remaining RPE-choroid cup for flattened choroid,which is immediately transferred for immunostaining treatment.Prior to immunostaining,the RPE-choroid complexes were blocked in 5% goat serum albumin (containing 0.3% Triton X-100) for 1 h at room temperature,followed by incubation with FITC-labeled isolectin-B4 (IB4) (FL-1201,Vector Laboratories,Burlingame,CA) at 4 °C.After overnight reaction,the RPE-choroid complexes were rinsed and transferred for incubation with Alexa Fluor 488-labelled secondary antibodies (SA00003-11,Proteintech,Chicago,MI) for 1 h at room temperature.Eventually,fluorescence images were conducted under a fluorescence microscope (Olympus,Tokyo,Japan) or a confocal laser scanning microscope (CLSM) (Leica TCS SP8,Leica TCS NT,Wetzlar,Germany).

    2.12.Statistical analysis

    The

    P

    values were determined based on the Student’s

    t

    -test using a two-tailed distribution and two-sample un-equal variance with the

    T

    .Test function of Microsoft Excel.The

    P

    values less than 0.05 were considered as statistically significant.

    3.Results and discussion

    3.1.Synthesis of block copolymeric RGD-PEG-PLys(thiol) and chemical characterizations

    Fig.1–Synthetic route in synthesis of block copolymeric RGD-PEG-PLys(thiol).

    The block copolymer of RGD-PEG-PLys(thiol) was synthesized according to Fig.1 .In brief,acetal-PEG-NH 2 was employed as the macro-initiator for ring-opening polymerization of the monomers of Lys(TFA)-NCA for production of acetal-PEG-PLys(TFA).Furthermore,the protecting TFA residues in the units of PLys(TFA) segment were removed under treatment in NaOH (0.1 N) to yield cationic bloc copolymer of acetal-PEG-PLys.Furthermore,the amino groups of lysine in acetal-PEG-PLys were used for conjugation of SPDP,followed by DTT treatment to yield the thiol groups.Ultimately,acetal-PEG-PLys(thiol) was incubated in acidic condition for transformation of the terminus acetal groups into aldehyde groups,which was schemed to react with cysteine groups from RGD to yield the ultimate block copolymer of RGD-PEG-PLys(thiol).The resulting copolymeric RGD-PEG-PLys(thiol),as well as the control copolymers of PEG-PLys,were characterized by bothH NMR and C-NMR measurements (Figs.S1–S5).As shown in Fig.S5,the polymerization degree of PLys segment was determined to be approximate 60.4,and the percentage of thiol substitution was estimated to be approximate 14.6% in relative to the total lysine units.Moreover,successful conjugation of cyclic RGD to the block copolymer was verified due to the evident peaks at 7.2–7.3 ppm,assignable to the protons from the phenyl groups of RGD,and the conjugation efficiency was estimated to exceed 97.2% per block copolymer.GPC measurement for the ultimate RGD-PEG-PLys(thiol) copolymer verified appreciable unimodal molecular weight distribution (Fig.S6).

    3.2.Fabrication of gene delivery systems based on electrostatic self-assembly and physiochemical characterizations

    The yielded functional block copolymer of RGD-PEG-PLys(thiol) was used to complex with polyanionic pDNA under gentle vortex,followed by 5 min incubation and sequential dialysis against DMSO-containing aqueous solution (DMSO:10 mM) and distilled water for disulfide crosslinking.Note that the positively charged PLys segments could electrostatically assemble with the negatively charged plasmid DNA (pDNA) into polyionic complex core,and the non-ionic hydrophilic PEG segments would surround the formed PLys/pDNA complex core as the external shells (Fig.2 A).The resulting formation of RGD-PEG-PLys(thiol)/pDNA was characterized by DLS.As shown in Fig.2 B,nanoscaled formation possessing approximate 61.2 nm in hydrodynamic diameter was confirmed with unimodal size distribution (PDI:0.09),which is contrast to the larger scale of naked pDNA (approximate 700 nm in hydrodynamic diameter by DLS measurement),suggesting the electrostatic condensation of pDNA by polycationic RGD-PEG-PLys(thiol) into favorable sub-100 nm nanoscale structures.Meanwhile,neutralization of the negative charges of pDNA (?38.4 mV) was also verified post complexation with RGD-PEG-PLys(thiol),as evidenced by the appreciable+2.4 mV for RGD-PEG-PLys(thiol)/pDNA.This appreciable neutral surface charge verified the excellent charge-masking function from PEG surface modification,which is critical in reducing electrostatic reactions in the complicated biological environment.Charge neutralization of pDNA was also confirmed by gel electrophoresis study for pDNA upon complexation with RGD-PEG-PLys(thiol)/pDNA at varied

    N

    /

    P

    ratios (defined as the molar ratio of the amine groups from block polymer to the phosphate groups from pDNA).As shown in Fig.S7,complete complexation of pDNA was identified at

    N

    /

    P

    ratios exceeding stochiometric charge ratio (

    N

    /

    P

    ≥ 1).Furthermore,the morphologies of pDNA condensates were characterized by TEM measurement.As shown in Fig.2 C,distinctive nanoscaled rod-like structures were observed,whose average length was measured to be approximate 100 nm.This distinctive rod-shape condensate is not surprising with respect that double-strand DNA (dsDNA) is rigid macromolecule,whose persistence length is approximate 50 nm in physiological condition.Consequently,the condensation of pDNA would follow a regular folding scheme into DNA bundles rather than collapse into spherical structures [24–26].Of note,the obtained rod-shaped nanostructures were reported to exert appreciable high cellular uptake activities,as well as high gene expression activities due to the facilitated transcription by means of the regular DNA folding scheme [26].

    Fig.2–Schematic illustration and physiochemical characterizations of synthetic gene delivery system from RGD-PEG-PLys(thiol).(A) Illustration in manufacture of multifunctional genomic nanoconstructs from self-assembly of RGD-PEG-PLys(thiol) and pDNA;(B) DLS (C):TEM for insight on the morphologies of RGD-PEG-PLys(thiol)/pDNA.Scale bar:100 nm.

    Fig.3–Insight on structural dissociation of pDNA self-assemblies from PEG-PLys and PEG-PLys(thiol) under incubation with polyanionic heparin at varied concentrations (units:mg/ml).

    3.3.Reversible stabilities of gene delivery systems due to redox crosslinking

    Aiming for adequate colloidal stabilities in the physiological environment,the aforementioned self-assemblies were introduced with redox-responsive crosslinking so as to withstand the potential exchange reactions and thus prevent the premature dissociation in the harsh physiological environment.As shown in gel electrophoresis (Fig.3),ready structural dissociation and thus liberation of the pDNA payloads was confirmed for PEG-PLys/pDNA self-assemblies (void of disulfide crosslinking) in presence of bio-existing polyanionic glycosaminoglycan (heparin:1.0 mg/ml).In contrast,the colloidal stabilities were observed to be substantially improved for PEG-PLys(thiol)/pDNA self-assemblies as evidenced by negligible pDNA liberation despite their incubation in presence of polyanionic heparin at a concentration of 5.0 mg/ml (Fig.3).This observation approved the functional role of disulfide crosslinking in strengthening colloidal stabilities of electrostatically-based self-assemblies in the biological milieu.Aside from adequate colloidal stabilities in the extracellular milieu,the proposed RGD-PEG-PLys(thiol)/pDNA self-assemblies is also designed to be capable of readily liberating the pDNA payloads in the cell interiors so as to facilitate the subsequent transcription and translation machinery.Given that the cell interior is characterized to be a significantly reducing compartment that commits to elimination of the detrimental reactive oxygen species,for instance,abundant reducing substances of glutathione (GSH) have documented in the cytosol (in the range of several 10–100 mM),yet the extracellular level of GSH was estimated to be in the range of serval 10–100 μM [27,28].Therefore,the redox-responsive disulfide linkage in the constructed nanocolloidals is envisioned to be selectively cleavable in the cytosol,while the disulfide crosslinking is fairly stable in extracellular milieu (including extracellular matrix and bloodstream).Consequently,the electrostatically-assembled nanocolloidals lack of chemical crosslinking are susceptible to exchange reactions with polyanionic species in view of diverse anionic polyanions existing in the intracellular compartment (e.g.nucleic acids) and on the cytoplasm structures (e.g.glycosaminoglycans),leadingly facilitating pDNA release for subsequent DNA transcription and translation machinery.In consistent with our speculation,readily pDNA release was confirmed for RGD-PEG-PLys(thiol)/pDNA self-assemblies in presence of GSH (50 mM,mimicking the intracellular milieu),comparable to PEG-PLys/pDNA.To this end,the facile redox-responsive stabilities were confirmed for the proposed RGD-PEG-PLys(thiol)/pDNA self-assemblies,which afford adequate colloidal stabilities in the extracellular environment but readily dissociation and release of pDNA payloads in the targeted cell interiors,thereby beneficial in accomplishing promoted gene expression in the targeted cells.

    3.4.Promoted cellular uptake and transfection due to disulfide crosslinking and surface RGD modification

    Fig.4–In vitro performance of a class of synthetic gene delivery systems upon incubation in HUVECs.(A) cellular uptake efficiencies,scale bar:20 μm;(B) gene expression efficiencies,scale bar:100 μm.

    Fig.5–Transgene expression of Gaussia luciferase after transfection to HUVEC spheroids using synthetic gene delivery system from RGD-PEG-PLys(thiol).

    Herein,the cellular uptake and gene expression efficiencies were evaluated in HUVECs.Note that HUVECs are angiogenic endothelial cells that widely used as the model cells representative for vascular endothelial cells.To start up,the cellular uptake efficiencies of a class of polyplex micelles,including PEG-PLys/pDNA,PEG-PLys(thiol)/pDNA and RGD-PEG-PLys(thiol)/pDNA,were evaluated in HUVECs by flow cytometry and CLSM measurements (Fig.4 A).Overall,cell uptake appeared for all the polyplex micelles,implying the importance of fabrication of nanoscaled DNA condensates in pursuit of cell internalization.In details,limited cellular uptake efficiency was confirmed for PEG-PLys/pDNA (Fig.4 A).Especially,no additional cell uptake was observed for PEG-PLys/pDNA after 4 h transfection (Fig.4 A),which should be as a result of its poor colloidal stabilities in the biological milieu.Presumably,PEG-PLys/pDNA was susceptible to structural dissociation in the extracellular conditions,and structural disassembly occurred within the initial 4 h incubation (Fig.3).Namely,minimal nanoscaled self-assemblies remain after 4 h incubation,therefore very limited cellular uptake efficiency could be expected despite extended incubation.On the contrary,consistent cellular uptake was observed for PEG-PLys(thiol)/pDNA,suggesting the validity of our disulfide strategy in enhancing colloidal stabilities to seek improved cellular uptake efficiency.To our interests,RGD-PEG-PLys(thiol) mediated highest level of cellular uptake (Fig.4 A).A plausible reason for this appreciable cellular uptake efficiency from RGD-PEG-PLys(thiol)/pDNA should be attributable to the specific affinity of RGD and its receptors which are overexpressed across a number of angiogenic cells (including HUVECs),consequently specific interactions between RGD ligand and receptors affording favorable cellular endocytosis activities into the angiogenic HUVECs.In consistent with cellular uptake results,the gene expression efficiency appeared to follow a similar trend (Fig.4 B),wherein the pDNA construct from RGD-PEG-PLys(thiol) presented highest transfection efficiency,markedly higher than the self-assemblies from PEG-PLys(thiol) and PEG-PLys.Hence,the self-assemblies from RGD-PEG-PLys(thiol) was ultimately employed for encapsulation of anti-VEGF gene for treatment of CNV.It is also should be noted that long-term gene expression was confirmed from our proposed genomic therapeutic (Fig.5).The proposed genomic construct encapsulating soluble Gaussia luciferase (Gluc)-encoding pDNA was attempted for transfection with HUVEC-based spheroids,and the extracellular expression of Gluc was quantified up to 32 d post transfection.As shown in Fig.5,consistent gene expression was observed,and no significant decline was confirmed despite extended incubation.This long-term gene expression profile is apparently favorable to the ultimate therapeutic outcomes,namely the therapeutic proteins from our proposed gene therapeutic strategy were believed to conduce to potent and enduring anti-angiogenic microenvironment to suppress the pathogenesis.

    3.5.Remarkable in vivo expression of anti-angiogenic proteins and potent suppression on CNV

    With the aim of suppressing CNV,an anti-VEGF gene (plasmid DNA) encoding soluble fms-related tyrosine kinase 1 (sFlt-1),was attempted as the genomic payloads for construction of gene delivery systems.In view that VEGF plays a fundamental role in promoting neovascularization and edema in wAMD,disruption of VEGF signaling should serve as a rational approach to interfere the progression of CNV.Herein,CNV were induced according to our previously established laser photocoagulation protocol.At 24 h post photocoagulation,CNV was confirmed by fluorescence angiography.To explore the therapeutic efficacy of our constructed anti-VEGF gene delivery systems,varied dosages of RGD-PEG-PLys(thiol)-based self-assemblies containing anti-VEGF pDNA (sFlt-1) was administered

    via

    intravitreous injection.The expression levels of the therapeutic payloads of sFlt-1 pDNA were evaluated in CNV regions by ELISA at 48 h post dosage.As shown in Fig.6 A,markedly sFlt-1 expression was confirmed from our proposed gene delivery systems from RGD-PEG-PLys(thiol),which is envisioned to endow anti-VEGF microenvironment in suppressing angiogenesis.Herein,the therapeutic efficacy was assessed by fluorescence angiography on Day 7 post treatment.As shown in Fig.6 B,aggressive neovasculature was observed for the control PBS group.On the contrary,the commercial VEGF antibody of Conbercept appeared to exert potent inhibition on progression of neovascularization,as evidenced by reduced angiogenic blood vessels.Noteworthy is the efficacy of our proposed gene delivery systems containing sFlt-1,which exhibited significant suppression in the growth of neovasculature (Fig.6 B).Close examination identified the suppression activities followed distinct dosage-dependent manner,and significant eradiation of neovasculature was achieved at dosage of 0.8 μg sFlt-1 pDNA.Furthermore,aiming for quantitatively estimation of the therapeutic efficacies,the vascular densities of the CNV lesions were quantified by calculating the positive areas of choroidal blood vessels post choroidal flatmount and immunostaining.Significant lowered CNV areas were confirmed for the sample of RGD-PEG-PLys(thiol)/sFlt-1 (Fig.7).It should be noted that,there was no significant difference between the PBS control group RGD-PEG-PLys(thiol)/Luc (containing non-therapeutic Luc gene),suggesting the obtained therapeutic efficacies as a result of expression of the loaded anti-angiogenic sFlt-1.Presumably,RGD-PEG-PLys(thiol)/sFlt-1 due to its specific affinity to the angiogenic endothelial cells,could preferentially accumulate in the blood vessels.Furthermore,the proposed redox-responsive motif of the proposed RGD-PEG-PLys(thiol)/sFlt-1 self-assembly allowed efficient gene expression in the targeted endothelial cells.The expressed sFlt-1,once secreted from the cells,manage to diffuse around and readily trap the angiogenic VEGF cytokines,ultimately contributing to inhibited neovasculature.Noteworthy is the therapeutic efficacy of our proposed gene delivery systems based on single dosage comparable to the most potent antibody-based therapeutics (Conbercept),validating its clinical potential in treatment of wAMD.Hence,the prosperous potential of anti-angiogenic strategy in treatment of wAMD was verified based on intravitreous injection of gene delivery systems encapsulating sFlt-1 gene.Aside from the therapeutic efficacy,appreciable safety profile was also confirmed for our constructed gene delivery systems,as evidenced by their excellent biocompatibilities.As shown in Fig.S8,negligible cytotoxicity was confirmed for the self-assemblies of RGD-PEG-PLys(thiol)/pDNA,meanwhile,minimal hemolysis was also verified when RGD-PEG-PLys(thiol)/pDNA was incubated with defibrinated sheep red blood cells.At 6 h post incubation,the hemolysis rates of RBCs were verified to be rather negligible (merely 2% even at a high concentration up to 0.2 mg/ml,Fig.S9),in stark contrast to the hemolysis rates of RBCs under incubation with amphiphiles of Tween80 to be 20.1% and 72.8% at the concentration of 0.25 and 1 mg/ml).Together with appreciable therapeutic efficacies,our proposed anti-angiogenic gene delivery system of RGD-PEG-PLys(thiol)/pDNA illustrates an intriguing tool for clinical persistent inhibition of CNV.

    Fig.6–Therapeutic assessment on our proposed anti-angiogenic therapeutics composed of RGD-PEG-PLys(thiol).(A) Quantification of the expressed sFlt-1 by ELISA.(B) Insight into the CNV leakage by ocular fluorescence angiography on Day 7 post treatment of synthetic gene delivery system from RGD-PEG-PLys(thiol) (< 1 ×> assigned to be 0.1 μg sFlt-1 pDNA).Note that intraperitoneal administration of fluorescein sodium was schemed prior to observation,scale bar:200 μm.

    Fig.7–Evaluation on choroidal vascular densities upon diverse treatment.(A) the choroidal flatmount images to illustrate neovasculatures,scale bar:100 μm;(B) the quantified densities of neovasculature were summarized into bar graph.

    4.Conclusions

    The rising population suffering from CNV encouraged tremendous efforts in development of potent therapeutics to tackle with this global leading cause for irreversible blindness.To manage this formidable disease,we are motivated to construct anti-angiogenic genomic therapeutics to verify the feasibility of gene therapy in treatment of CNV.In the present study,synthetic gene delivery system was rationally tailored with multifunctional motifs,including active targeting function to the angiogenic endothelial cells,stimuli-responsive stabilities to release the DNA payloads selectively in the cell interiors,which consequently contributed to efficient gene expression at the targeted cells.Note that the constructed delivery system encapsulating anti-angiogenic gene was determined to accomplish potent CNV suppression.Therefore,our proposed gene delivery system implied tremendous potential of gene therapy as an alternative approach for treatment of CNV.Considering the versatile genomic tools available in gene therapy,for instance,Crispr/Cas gene editing or RNA interference,our proposed gene delivery system could be further exploited to find broad utilities in achieving appropriate therapeutic consequences in treatment of intractable ocular diseases.

    Conflicts of interest

    The authors declare no competing financial interest.

    Acknowledgments

    This research was funded by National Natural Science Foundation of China (81900869,81730026,81802482),National Key R&D Program (2019YFC0840607,2017YFA0105301),Science and Technology Commission of Shanghai Municipality (17411953000,19495800700),Shanghai Sailing Program (19YF1439500),Talent Project of Revitalizing Liaoning (XLYC1807184),and Dalian Science&Technology Innovation Fund (2020JJ26SN050).

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.ajps.2021.04.001 .

    久久久国产一区二区| 最近中文字幕高清免费大全6| 欧美zozozo另类| 五月天丁香电影| 69av精品久久久久久| 亚洲精品视频女| 日韩中字成人| 免费观看a级毛片全部| 精品国产三级普通话版| 亚洲精品,欧美精品| 免费大片黄手机在线观看| 日韩一区二区视频免费看| 亚洲av不卡在线观看| 亚洲aⅴ乱码一区二区在线播放| 美女大奶头视频| 免费观看无遮挡的男女| 国产黄a三级三级三级人| 亚洲av福利一区| 国产高清有码在线观看视频| 最近视频中文字幕2019在线8| 视频中文字幕在线观看| 国产免费视频播放在线视频 | 国产综合懂色| 又黄又爽又刺激的免费视频.| 免费观看精品视频网站| 亚洲性久久影院| 少妇高潮的动态图| 一个人看的www免费观看视频| 一区二区三区高清视频在线| 亚洲欧美精品专区久久| 少妇丰满av| 国产精品人妻久久久影院| 色综合站精品国产| 欧美激情在线99| 男插女下体视频免费在线播放| 亚洲欧美一区二区三区国产| 亚洲欧美一区二区三区国产| 美女高潮的动态| 国产一级毛片在线| 国产一级毛片在线| 十八禁国产超污无遮挡网站| 午夜精品国产一区二区电影 | 69人妻影院| 在线观看免费高清a一片| 日韩欧美精品免费久久| 欧美xxxx黑人xx丫x性爽| 91久久精品国产一区二区成人| 亚洲欧美日韩卡通动漫| 能在线免费看毛片的网站| 2021少妇久久久久久久久久久| 亚洲精品第二区| 女人被狂操c到高潮| 午夜精品国产一区二区电影 | 好男人在线观看高清免费视频| 国产黄色视频一区二区在线观看| 日韩一区二区三区影片| 嘟嘟电影网在线观看| 久久精品国产鲁丝片午夜精品| 又爽又黄a免费视频| 日本一本二区三区精品| 啦啦啦韩国在线观看视频| 国产色婷婷99| 亚洲国产日韩欧美精品在线观看| 伊人久久精品亚洲午夜| 亚洲av二区三区四区| 精品不卡国产一区二区三区| 成人毛片60女人毛片免费| 亚洲精品久久久久久婷婷小说| 男女下面进入的视频免费午夜| 777米奇影视久久| 成人漫画全彩无遮挡| 久久97久久精品| 亚洲va在线va天堂va国产| 国产片特级美女逼逼视频| 亚洲欧美一区二区三区国产| 国产精品蜜桃在线观看| 国产大屁股一区二区在线视频| 欧美变态另类bdsm刘玥| 尾随美女入室| 网址你懂的国产日韩在线| 免费观看av网站的网址| 国产爱豆传媒在线观看| 婷婷色麻豆天堂久久| 日韩伦理黄色片| 国产精品一及| 丰满乱子伦码专区| 高清av免费在线| 最近视频中文字幕2019在线8| 色播亚洲综合网| 18禁裸乳无遮挡免费网站照片| 男人爽女人下面视频在线观看| 少妇熟女欧美另类| 午夜福利成人在线免费观看| 夜夜爽夜夜爽视频| 久久久久免费精品人妻一区二区| 国产精品.久久久| 人体艺术视频欧美日本| 国产爱豆传媒在线观看| 久久99蜜桃精品久久| 国产精品国产三级国产av玫瑰| 色综合站精品国产| 亚洲aⅴ乱码一区二区在线播放| 欧美成人一区二区免费高清观看| 国产精品嫩草影院av在线观看| 亚洲欧美一区二区三区国产| 亚洲精品国产av蜜桃| 久久精品熟女亚洲av麻豆精品 | 亚洲av国产av综合av卡| 国产真实伦视频高清在线观看| 丰满人妻一区二区三区视频av| 成人特级av手机在线观看| 在线观看免费高清a一片| 国产片特级美女逼逼视频| 成年免费大片在线观看| 国产 一区 欧美 日韩| 亚洲国产日韩欧美精品在线观看| 欧美日韩综合久久久久久| 天堂影院成人在线观看| 欧美日本视频| 国产精品1区2区在线观看.| av在线观看视频网站免费| 菩萨蛮人人尽说江南好唐韦庄| 日本猛色少妇xxxxx猛交久久| 国产av国产精品国产| 中文乱码字字幕精品一区二区三区 | 亚洲国产成人一精品久久久| 久久精品熟女亚洲av麻豆精品 | 精华霜和精华液先用哪个| 国产成人精品婷婷| 国产精品女同一区二区软件| 久久久久九九精品影院| 美女高潮的动态| 日本一本二区三区精品| 免费看光身美女| 边亲边吃奶的免费视频| 久久国产乱子免费精品| 天堂√8在线中文| 91精品伊人久久大香线蕉| 精品人妻熟女av久视频| 亚洲国产精品国产精品| 99re6热这里在线精品视频| 久久热精品热| 国产精品av视频在线免费观看| 深爱激情五月婷婷| 亚洲婷婷狠狠爱综合网| 国产亚洲一区二区精品| 国产高清三级在线| 国产午夜精品论理片| 亚洲国产高清在线一区二区三| 国产黄频视频在线观看| 看非洲黑人一级黄片| 黑人高潮一二区| 国产黄色小视频在线观看| 国产精品久久久久久精品电影小说 | 人妻制服诱惑在线中文字幕| 精品国产露脸久久av麻豆 | 嫩草影院精品99| 亚洲av免费高清在线观看| 麻豆乱淫一区二区| 日本一本二区三区精品| 伦精品一区二区三区| 精品熟女少妇av免费看| 少妇被粗大猛烈的视频| 舔av片在线| 好男人在线观看高清免费视频| 精品亚洲乱码少妇综合久久| 欧美激情国产日韩精品一区| 天天躁夜夜躁狠狠久久av| 99热网站在线观看| 一夜夜www| 最近2019中文字幕mv第一页| 直男gayav资源| 日韩成人伦理影院| 国产成人精品久久久久久| 国产精品av视频在线免费观看| 青春草亚洲视频在线观看| 亚洲精品国产av成人精品| 国产精品久久久久久久久免| 人人妻人人看人人澡| 欧美xxⅹ黑人| 精品一区二区免费观看| 搡老妇女老女人老熟妇| 国产成人aa在线观看| av黄色大香蕉| 中文资源天堂在线| 在线观看av片永久免费下载| 我的女老师完整版在线观看| 一级二级三级毛片免费看| 久久久久精品性色| 伊人久久国产一区二区| 天天一区二区日本电影三级| 天天躁夜夜躁狠狠久久av| 国产亚洲91精品色在线| 亚洲婷婷狠狠爱综合网| 狂野欧美白嫩少妇大欣赏| 亚洲av成人精品一区久久| 亚洲经典国产精华液单| 日本午夜av视频| 亚洲av电影在线观看一区二区三区 | 亚洲国产欧美在线一区| 毛片一级片免费看久久久久| 亚洲成人一二三区av| 成人欧美大片| 日本黄大片高清| 国产成人免费观看mmmm| 一个人观看的视频www高清免费观看| 色视频www国产| 国产伦一二天堂av在线观看| 国产高潮美女av| 我的女老师完整版在线观看| 国产成人a∨麻豆精品| 嘟嘟电影网在线观看| 国产成人午夜福利电影在线观看| 国产免费福利视频在线观看| 搡女人真爽免费视频火全软件| 日日干狠狠操夜夜爽| 国产中年淑女户外野战色| 国产大屁股一区二区在线视频| 精品酒店卫生间| 少妇人妻一区二区三区视频| 少妇裸体淫交视频免费看高清| 最近的中文字幕免费完整| 欧美97在线视频| 国产av码专区亚洲av| 久久精品国产自在天天线| 亚洲最大成人av| 好男人在线观看高清免费视频| 国产在线一区二区三区精| 不卡视频在线观看欧美| 黄片无遮挡物在线观看| 欧美日韩国产mv在线观看视频 | 26uuu在线亚洲综合色| 综合色丁香网| 久久精品国产亚洲网站| 亚洲丝袜综合中文字幕| 欧美xxⅹ黑人| 亚洲18禁久久av| 久久国内精品自在自线图片| 国产精品伦人一区二区| 日日摸夜夜添夜夜添av毛片| 成人毛片60女人毛片免费| 亚洲av成人av| 99久国产av精品国产电影| 丝袜喷水一区| 亚洲电影在线观看av| 菩萨蛮人人尽说江南好唐韦庄| 日本爱情动作片www.在线观看| 国产麻豆成人av免费视频| 国产免费又黄又爽又色| 国产有黄有色有爽视频| 国产一区二区在线观看日韩| 国产高清国产精品国产三级 | 亚洲欧美日韩无卡精品| 国产精品女同一区二区软件| 非洲黑人性xxxx精品又粗又长| 亚洲三级黄色毛片| 日韩一本色道免费dvd| 床上黄色一级片| 简卡轻食公司| 国产在线男女| 午夜福利在线在线| 我要看日韩黄色一级片| 人妻系列 视频| 国产欧美日韩精品一区二区| 夜夜看夜夜爽夜夜摸| 日本wwww免费看| 五月玫瑰六月丁香| 午夜免费激情av| 国产色爽女视频免费观看| 白带黄色成豆腐渣| 久久久成人免费电影| 欧美激情在线99| 亚洲美女搞黄在线观看| 亚洲成色77777| 久久这里只有精品中国| 两个人视频免费观看高清| 女的被弄到高潮叫床怎么办| 国产成人freesex在线| 亚洲欧美成人综合另类久久久| 能在线免费看毛片的网站| 内地一区二区视频在线| 国内精品一区二区在线观看| 亚洲乱码一区二区免费版| 最近中文字幕高清免费大全6| 91精品国产九色| 白带黄色成豆腐渣| 亚洲av男天堂| 男插女下体视频免费在线播放| 99热这里只有是精品50| 精品熟女少妇av免费看| 亚洲国产欧美在线一区| 日本欧美国产在线视频| 国产淫语在线视频| 国产永久视频网站| 最近视频中文字幕2019在线8| 国产69精品久久久久777片| 亚洲性久久影院| 只有这里有精品99| 99九九线精品视频在线观看视频| 国产视频内射| 国产伦在线观看视频一区| 少妇人妻一区二区三区视频| 91久久精品国产一区二区成人| 高清在线视频一区二区三区| 国产有黄有色有爽视频| 亚洲av福利一区| 亚洲精品第二区| 不卡视频在线观看欧美| 国内揄拍国产精品人妻在线| 嫩草影院入口| 亚洲国产精品国产精品| 亚洲电影在线观看av| 午夜激情久久久久久久| 成人av在线播放网站| 亚洲欧美成人精品一区二区| 亚洲真实伦在线观看| 美女xxoo啪啪120秒动态图| 少妇熟女欧美另类| 特级一级黄色大片| 精品久久久久久久久亚洲| videossex国产| 国产成人精品一,二区| 国产女主播在线喷水免费视频网站 | 成人午夜高清在线视频| 国产乱人偷精品视频| 国产精品一区二区性色av| 久久精品综合一区二区三区| 亚洲一区高清亚洲精品| 欧美不卡视频在线免费观看| 亚洲国产av新网站| 日本一二三区视频观看| 欧美变态另类bdsm刘玥| 哪个播放器可以免费观看大片| 亚洲精品影视一区二区三区av| 又爽又黄无遮挡网站| 欧美人与善性xxx| 国产午夜福利久久久久久| 久久久久久久久大av| 亚洲国产精品成人综合色| 国产精品国产三级国产专区5o| 大香蕉久久网| 久久久久久久久久黄片| 亚洲人与动物交配视频| 尾随美女入室| 久久久久精品久久久久真实原创| 亚洲精品国产av成人精品| 国产探花在线观看一区二区| 日产精品乱码卡一卡2卡三| 日日摸夜夜添夜夜爱| 日本三级黄在线观看| 国产精品久久久久久久电影| 一级a做视频免费观看| 人妻系列 视频| 伦理电影大哥的女人| 99久久精品热视频| 五月天丁香电影| 亚洲欧美成人精品一区二区| 国内揄拍国产精品人妻在线| 禁无遮挡网站| 伊人久久精品亚洲午夜| 日韩av免费高清视频| 精品人妻熟女av久视频| 亚洲欧美日韩东京热| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 床上黄色一级片| 亚洲av不卡在线观看| 人妻夜夜爽99麻豆av| 久久6这里有精品| 日韩电影二区| 亚洲欧美日韩无卡精品| 精品久久久精品久久久| 久久久精品免费免费高清| 亚洲自拍偷在线| 亚洲va在线va天堂va国产| 可以在线观看毛片的网站| 美女大奶头视频| 国内精品宾馆在线| 亚洲精品一二三| 婷婷六月久久综合丁香| 中文乱码字字幕精品一区二区三区 | 国产爱豆传媒在线观看| 91在线精品国自产拍蜜月| av在线老鸭窝| 国产黄频视频在线观看| 一个人观看的视频www高清免费观看| 午夜精品一区二区三区免费看| 黄片无遮挡物在线观看| 日韩欧美精品免费久久| 久久久久久久久中文| 亚洲欧洲国产日韩| 国产精品美女特级片免费视频播放器| 白带黄色成豆腐渣| 丰满乱子伦码专区| 国产久久久一区二区三区| 中文字幕av成人在线电影| 69av精品久久久久久| 波多野结衣巨乳人妻| 精品人妻视频免费看| 婷婷色综合www| 欧美激情国产日韩精品一区| 97超视频在线观看视频| 女人被狂操c到高潮| 99视频精品全部免费 在线| 国产精品女同一区二区软件| 干丝袜人妻中文字幕| 99视频精品全部免费 在线| 亚洲av成人av| 亚洲最大成人手机在线| 天堂av国产一区二区熟女人妻| 国产亚洲5aaaaa淫片| 激情 狠狠 欧美| 老女人水多毛片| 国产一区二区三区av在线| 性色avwww在线观看| 18+在线观看网站| 国产欧美另类精品又又久久亚洲欧美| 如何舔出高潮| 久久久久久九九精品二区国产| 久久韩国三级中文字幕| 99久久精品一区二区三区| 久久99热这里只有精品18| 亚洲精品第二区| 亚洲欧美精品自产自拍| 亚洲国产精品成人综合色| 国产成人午夜福利电影在线观看| 久久久久久久久久黄片| 久久草成人影院| 两个人的视频大全免费| 久久韩国三级中文字幕| 久久亚洲国产成人精品v| 国产一区亚洲一区在线观看| 欧美成人精品欧美一级黄| 婷婷色麻豆天堂久久| 亚洲av免费高清在线观看| 亚洲色图av天堂| 国产综合精华液| 久久久精品免费免费高清| 最近最新中文字幕免费大全7| 男人狂女人下面高潮的视频| 国产高潮美女av| 亚洲综合精品二区| 女人久久www免费人成看片| 免费看美女性在线毛片视频| 欧美变态另类bdsm刘玥| 久久午夜福利片| 亚洲性久久影院| 狂野欧美激情性xxxx在线观看| 日韩电影二区| www.av在线官网国产| 久久精品夜夜夜夜夜久久蜜豆| 一级黄片播放器| 日本黄大片高清| 六月丁香七月| 伊人久久精品亚洲午夜| 男女国产视频网站| 亚洲av成人精品一区久久| 久久久久精品久久久久真实原创| 免费在线观看成人毛片| 亚洲欧美精品自产自拍| av卡一久久| 少妇熟女aⅴ在线视频| 久久久精品欧美日韩精品| 免费观看精品视频网站| 亚洲综合色惰| 免费看av在线观看网站| 91午夜精品亚洲一区二区三区| 一区二区三区免费毛片| 精品少妇黑人巨大在线播放| or卡值多少钱| 亚洲丝袜综合中文字幕| 99久久中文字幕三级久久日本| 午夜精品国产一区二区电影 | 亚洲精品456在线播放app| 久久久午夜欧美精品| 亚洲欧美中文字幕日韩二区| 国产熟女欧美一区二区| 一二三四中文在线观看免费高清| 97超碰精品成人国产| 精品久久国产蜜桃| 免费少妇av软件| 高清日韩中文字幕在线| 亚洲人成网站在线播| 自拍偷自拍亚洲精品老妇| 日韩 亚洲 欧美在线| 国产成人精品久久久久久| 欧美日韩国产mv在线观看视频 | 成年人午夜在线观看视频 | 亚洲av.av天堂| 久久久久久久国产电影| 亚洲欧美日韩无卡精品| 少妇熟女欧美另类| 日韩av不卡免费在线播放| 国内精品宾馆在线| 欧美日韩综合久久久久久| 一二三四中文在线观看免费高清| 日韩成人伦理影院| 日本猛色少妇xxxxx猛交久久| 成人美女网站在线观看视频| 九九久久精品国产亚洲av麻豆| av在线播放精品| 色5月婷婷丁香| or卡值多少钱| 亚洲丝袜综合中文字幕| 亚洲av福利一区| 国产 一区 欧美 日韩| 国产精品久久久久久精品电影| 直男gayav资源| 国内揄拍国产精品人妻在线| 蜜桃亚洲精品一区二区三区| 久久热精品热| 国产美女午夜福利| 男的添女的下面高潮视频| 国内精品宾馆在线| 国产老妇女一区| av国产久精品久网站免费入址| 黄色一级大片看看| 欧美日韩视频高清一区二区三区二| 熟妇人妻久久中文字幕3abv| 偷拍熟女少妇极品色| 色5月婷婷丁香| 中国国产av一级| 欧美+日韩+精品| 日韩成人av中文字幕在线观看| 91精品一卡2卡3卡4卡| 九色成人免费人妻av| 成人美女网站在线观看视频| 色吧在线观看| 日日啪夜夜爽| 久久久久精品久久久久真实原创| 亚洲av电影不卡..在线观看| 国产 一区精品| 成人二区视频| 亚洲欧美日韩无卡精品| 蜜桃亚洲精品一区二区三区| 国产黄频视频在线观看| 亚洲成人一二三区av| 亚洲乱码一区二区免费版| 国产视频内射| 亚洲欧美精品专区久久| 国产乱来视频区| 人人妻人人澡欧美一区二区| 人妻系列 视频| 亚洲精品,欧美精品| 亚洲一区高清亚洲精品| 人人妻人人澡欧美一区二区| 久久99热6这里只有精品| 日本与韩国留学比较| 麻豆av噜噜一区二区三区| 亚洲精品自拍成人| 51国产日韩欧美| 只有这里有精品99| 建设人人有责人人尽责人人享有的 | 国产av在哪里看| 国产乱来视频区| 亚洲精品日韩av片在线观看| 国产69精品久久久久777片| 亚洲真实伦在线观看| 麻豆乱淫一区二区| 亚洲精品自拍成人| 久久99热6这里只有精品| 亚洲乱码一区二区免费版| 三级国产精品片| 亚洲国产精品sss在线观看| 日韩一区二区三区影片| 久久99精品国语久久久| 国产v大片淫在线免费观看| 又大又黄又爽视频免费| 亚洲国产精品国产精品| 久久久久久伊人网av| 国产一区有黄有色的免费视频 | 日本欧美国产在线视频| 精品熟女少妇av免费看| 久久久久精品性色| 男女啪啪激烈高潮av片| 三级国产精品片| 日韩中字成人| 精品亚洲乱码少妇综合久久| 高清日韩中文字幕在线| 国产精品麻豆人妻色哟哟久久 | 99久久人妻综合| 99久久中文字幕三级久久日本| 99热这里只有是精品50| 2018国产大陆天天弄谢| 国产午夜精品一二区理论片| 精品一区在线观看国产| 亚洲性久久影院| 久久6这里有精品| 夫妻性生交免费视频一级片| 久久国内精品自在自线图片| 大话2 男鬼变身卡| 欧美xxxx性猛交bbbb| 国产亚洲5aaaaa淫片| 国产精品蜜桃在线观看| www.色视频.com| 天堂网av新在线| 国产精品日韩av在线免费观看| 国产伦一二天堂av在线观看| 色播亚洲综合网| 高清午夜精品一区二区三区| 日韩亚洲欧美综合| 久久久午夜欧美精品| 国产精品伦人一区二区| 亚洲欧美成人综合另类久久久| 免费黄频网站在线观看国产| 高清av免费在线| 91狼人影院| 亚洲高清免费不卡视频| 亚洲欧美一区二区三区黑人 | 日韩成人av中文字幕在线观看| 久久久久国产网址| 亚洲国产最新在线播放| av在线蜜桃| 麻豆精品久久久久久蜜桃| 日韩精品有码人妻一区| 亚洲av成人精品一区久久|